Literature DB >> 6818154

Pseudomonas aeruginosa meningitis treated with an azlocillin combination.

S Davidson, E O Yellin, I Shaked, E Rubinstein.   

Abstract

Pseudomonas aeruginosa meningitis following trauma or surgery is associated with a high mortality rate. This high rate is explained both by tissue damage which leads to infection and by the failure of antibacterial therapy. The latter is due to the relatively resistant microorganism and the insufficient penetration of antibiotics into the CSF. We are reporting the successful therapy of a case of postoperative P. aeruginosa meningitis treated with the combination of azlocillin and gentamicin administered systemically together with intraventricular gentamicin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818154     DOI: 10.1007/bf01640663

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Pseudomonas meningitis: report of a case.

Authors:  S L NUNN; W E WELLMAN
Journal:  Med Clin North Am       Date:  1960-07       Impact factor: 5.456

2.  Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections.

Authors:  H C Neu; H Swarz
Journal:  Ann Intern Med       Date:  1969-11       Impact factor: 25.391

3.  Pseudomonas meningitis treated with azlocillin.

Authors:  C J Ellis; P H Walter
Journal:  Br Med J       Date:  1979-09-29

4.  Aminoglycoside therapy of gram-negative bacillary meningitis.

Authors:  A B Kaiser; Z A McGee
Journal:  N Engl J Med       Date:  1975-12-11       Impact factor: 91.245

Review 5.  Antimicrobial agents and the central nervous system.

Authors:  E D Everett; L J Strausbaugh
Journal:  Neurosurgery       Date:  1980-06       Impact factor: 4.654

6.  Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.

Authors:  L Coppens; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Treatment of childhood meningitis with mezlocillin.

Authors:  J Llorens-Terol; A Lobato; D Adam
Journal:  Arzneimittelforschung       Date:  1979

8.  Cerebrospinal fluid penetration of mezlocillin.

Authors:  J Modai; J Pierre; E Bergogne-Berezin; M F Avril
Journal:  Arzneimittelforschung       Date:  1979

9.  Comparative trial of carbenicillin and ampicillin therapy for purulent meningitis.

Authors:  G D Overturf; E A Steinberg; A E Underman; J Wilkins; J M Leedom; A W Mathies; P F Wehrle
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

  9 in total
  1 in total

1.  [Cefsulodin in the treatment of Pseudomonas meningitis].

Authors:  O Brückner; H Collmann; M Trautmann
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.